HSE to shave tens of millions off drug bill with launch of cheaper alternative

Susan Mitchell

Deputy Editor and Health Editor @susmitchellsbp
25th November, 2018
Huilo is the new drug that has been launched

Mylan has launched a new drug that will result in significant price savings on the state’s €124 million annual bill for Humira, which the HSE spends more on than any other drug on the market.

Humira, a biological drug that is manufactured by AbbVie, is predominantly used to treat rheumatoid arthritis, but also Crohn’s disease, colitis and psoriasis. The HSE pays approximately €1,080 per month for a dose of Humira (80mg), but that...

Subscribe from just €1 for the first month!


What's Included

With any subscription you will have access to

  • 971569B3-2C5E-4C45-B798-CEADE16987A8

    Unlimited multi-device access to our iPad, iPhone and Android Apps

  • 099C8662-C57C-42F2-9426-F2F90DF17C8F

    Unlimited access to our eReader library

  • 198AE43B-B9CF-4892-8769-D63C2104BA08

    Exclusive daily insight and opinion seven days a week

  • D8F37B78-25E4-4E4A-A376-4F5789B1564A

    Create alerts to never miss a subject that matters to you

  • B15F2521-37CD-4E02-B898-730A20D39F7F

    Get access to exclusive offers for subscribers on gifts and experiences

  • A564FE02-1AB8-4579-AF9D-BA32A2E5ACA7

    Get content from Business Post, Business Post Magazines, Connected, Tatler and Food & Wine

Share this post

Related Stories

Tony O’Brien: Health’s other challenges now need the same urgent care as Covid

Health Tony O'Brien 16 hours ago

New public-only deals for medical consultants set for this summer

Health Daniel Murray 16 hours ago

HSE contacts Data Protection Commission over ransomware attack

Health Donal MacNamee 2 days ago

Comment: Our reserves were not built to survive long Covid

Health Sarah O'Connor 1 week ago